4D pharma is a world leader in the development of Live Biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacterium, that is applicable to the prevention, treatment or cure of a disease.? 4D has developed a proprietary platform, MicroRx®, that rationally identifies Live Biotherapeutics based on a deep understanding of function and mechanism. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:DDDD.
$1.65
As of 06/24/2022 IEX book CBOE book
2022 © Stock Market MBA, Inc.